Drug Database
Back to search

United Kingdom· GB-APID-10424511000001109

3,4-Diaminopyridine 20mg tablets

A amifampridine product containing amifampridine, registered in United Kingdom by Special Order. The same ATC class is registered in 16 of our 19 countries.

ATC N07XX05

Checked against NHS dm+d (United Kingdom) on

Informational only — not a medical device.

SOURCE REGISTER · GBNHS dm+d (United Kingdom)normalised3,4-Diaminopyridine 20mg tabletsATCN07XX05REGISTER NO.GB-APID-1042451100000…PACKS LISTED0CHECKEDSeptember 13, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about amifampridineAnswers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

Where it is registered

Amifampridine is registered in 16 of 19 countries.

Countries holding a registration under ATC N07XX05 (amifampridine), each read from that country’s own register.

  • This record: United Kingdom, from NHS dm+d (United Kingdom)
  • 9 of them publish a price we can compare per daily dose
Search amifampridine products by name

Amifampridine · ATC N07XX05

16 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Franceprice
  • Germany
  • Icelandprice
  • Ireland
  • Netherlands
  • Norwayprice
  • Polandprice
  • Sweden
  • Switzerlandprice
  • United Kingdom
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of amifampridine costs, country by country.

Normalised to the WHO defined daily dose (40 mg), the median price runs from $75.59 in Switzerland to $3657.38 in France — a ×48 gap.

  • 2 markets with a comparable price for this class
  • Public list prices, converted to USD at the rate date shown
Open the full comparison — free accountDrug prices for market access

Amifampridine · price per daily dose (40 mg)

USD · FX 28 Sept 2026

  • FR France$3657.38
  • CH Switzerland$75.59
Median listed price per WHO defined daily dose, in each market that publishes a price. Open the full comparison

The record

At a glance

NHS dm+d (United Kingdom)
Active substance
Amifampridine
Manufacturer
Special Order
Country
United Kingdom (GB)
ATC code
N07XX05
ATC class
Amifampridine
Defined daily dose
40 mg, O
Reimbursed
Not published by this register
Source register
NHS dm+d (United Kingdom)
Last checked
September 13, 2026

Packs & prices · 0

No packs listed by the register for this record.

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

82 interactions on record for amifampridine.

Graded by severity as the source publishes them — 4 severe. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan
Check amifampridine against other medicinesHow interaction checks work

Amifampridine · interactions on record

82 records

  • 4 severe
  • 78 moderate

Most severe, free to view

  • BupropionN06AX12severe
  • BupropionN07BA02severe
  • IohexolV08AB02severe
  • IopamidolV08AB04severe
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Amifampridine in 14 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All amifampridine products

Authorised across Europe · EMA

The same active substance is authorised in 11 EEA countries. Names it is sold under:

  • Germany · Amifampridin Accord, Amifampridin Amarox
  • France · Amifampridine Amarox, Amifampridine Biogaran
  • Hungary · Amifampridine Accord
  • Iceland · Amifampridine Serb, Firdapse
  • Italy · Amifampridina Accord
  • Liechtenstein · Amifampridine Serb, Firdapse
  • Netherlands · Amifampridine Accord, Amifampridine Amarox
  • Norway · Amifampridin Medical Valley, Amifampridine Accord
  • Poland · Amifampridine Medical Valley
  • Portugal · Amifampridina Accord, Amifampridina Generis
  • Slovenia · Amifampridin Accord

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of NHS dm+d (United Kingdom). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/0ab8a4a2-344c-46c4-b952-39d3fa20f8e3
GET /v1/drugs/0ab8a4a2-344c-46c4-b952-39d3fa20f8e3?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "apid": "10424511000001109",
  "desc": "3,4-Diaminopyridine 20mg tablets (Special Order)",
  "form": "Oral tablet",
  "vpid": "10424311000001103",
  "source": "dmd",
  "vtm_id": "782984006",
  "strength": "20 mg",
  "substance": "Amifampridine",
  "ingredient": "Amifampridine",
  "supplier_code": "8286711000001104"
}
API referenceMCP serverPlans

See everything about amifampridine.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it freeOpen in the console